TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05087290

Intervention type: OTHER
Intervention: Cases
Description: All performed at baseline, 12 months and 18 months Medical and drug history Anthropometric tests Electrocardiogram Brachial flow mediated dilatation 6 minute walk test Blood sampling Urine sampling 24-hr Ambulatory Blood Pressure Monitor Questionnaires~Optional:~Stool sampling,24-hr Urine collection, Home Blood Pressure Monitor

Intervention type: OTHER
Intervention: Controls
Description: All performed at baseline, 12 months and 18 months Medical and drug history Anthropometric tests Electrocardiogram Brachial flow mediated dilatation 6 minute walk test Blood sampling Urine sampling 24-hr Ambulatory Blood Pressure Monitor Questionnaires~Optional:~Stool sampling,24-hr Urine collection, Home Blood Pressure Monitor
Study: NCT04911803

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Anxiety Application
Description: The Intellect mobile app (containing the anxiety application) can be freely downloaded from the App store and Google Play store for free. The app provides access to the different programmes. The mobile app has been pilot tested by Intellect before the release on the App and Google Play store. However, for this research project Intellect is going to provide the the programmes as stand alone applications exclusively for the participants of this research.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Procrastination Application
Description: The Intellect mobile app (containing the procrastination application) can be freely downloaded from the App store and Google Play store for free. The app provides access to the different programmes. The mobile app has been pilot tested by Intellect before the release on the App and Google Play store. However, for this research project Intellect is going to provide the the programmes as stand alone applications exclusively for the participants of this research.
Study: NCT04776382

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EMME (Eye Movement Modeling Examples)
Description: Trainees of this group will watch an EMME (Eye Movement Modeling Examples)-recorded video, on where to focus their gaze while performing the epidural procedure in accordance with expert eye-tracking
Study: NCT06356961

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: (Feedback Informed Therapy) with Clinical Support Tools and ah hoc training
Description: Therapists in the condition (OPM-F) will receive specific training on the procedures and techniques inherent in feedback informed therapy (FIT); during the intervention phase (lasting 15 sessions) the Clinical Support System in FIT will guide them in the clinical application of the procedures. In addition, they will receive monthly supervision (for three months) apt to provide on-going clinical support on FIT and ROM, with practical discussion of the most difficult clinical cases and possible solutions to be implemented in therapy.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Feedback and ROM (basic)
Description: Process and outcome monitoring (OPM) in which patients will complete process and outcome measures related to each psychotherapy session but therapists will receive basic feedback on these measures

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feedback and ROM (basic)
Description: Process and outcome monitoring (OPM) in which patients will complete process and outcome measures related to each psychotherapy session but therapists will receive basic feedback on these measures
Study: NCT05433506

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HU6 Tablet
Description: Six subjects will receive a tablet formulation.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HU6 Capsule
Description: Six subjects will receive the capsule formulation
Study: NCT05363475

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ForeSite Intelligent Surface
Description: The ForeSite IS is a continuous bedside pressure mapping system with machine learning and artificial intelligence (ML/AI). It consists of an overlay with over 1500 undetectable integrated sensors and a medical-grade bedside touchscreen monitor. The monitor displays a real-time coloured body pressure image, a turn timer, and a history of previous turns. The ML/AI software tracks 17 body locations and the patient's body position. The system has a centralized dashboard that shows the pressure injury risk and turn history, which can be transmitted to the nursing station. In addition, data is stored in an Amazon Web Services (AWS) secured cloud database, enabling access to individual reports on turn history and compliance and pressure exposure. Data is stored as both, raw pressure data files and real time event information on pressure exposure and turn data.
Study: NCT05178238

Intervention type: OTHER
Intervention: Fecal sample
Description: Fecal sample taken to investigate intestinal microbiota

Intervention type: OTHER
Intervention: Fecal sample
Description: Fecal sample taken to investigate intestinal microbiota
Study: NCT03303742

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: deep chamfer
Description: finish line marginal design of a full coverage crown preparation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: feather edge
Description: finish line marginal design of a full coverage crown preparation
Study: NCT05842538

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Triathlon
Description: Total knee arthroplasty

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Triathlon
Description: Total knee arthroplasty
Study: NCT05749627

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neoantigen peptide vaccine
Description: Personalized tumor neoantigen peptide vaccine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neoantigen-based DC immune preparation
Description: Personalized tumor neoantigen DC therapeutic immune preparation
Study: NCT04216069

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Total 12 regimen
Description: The volunteers will be invited with their caregivers to a lecture administered with the aim of clarifying the importance of oral hygiene and motivating brushing among the volunteers. Written clarifications will also be given in the form of an illustrative pamphlet. The volunteers will be trained in the technique through supervised brushing in front of a mirror. Subjects from the Group 1 will use a regimen with Colgate Total 12 toothpaste + Plax mouthwash + Colgate Ultrasoft toothbrush. Subjects will be instructed to use only their assigned group during the study period. The treatment products will be re-supplied at regular intervals. Subjects will return with their assigned products to the study site before receiving new products.~There will be no restrictions regarding diet habits during the course of the study. Upon completion of the study, subjects will be instructed to return all used and used products.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Toothbrushing alone
Description: The volunteers will be invited with their caregivers to a lecture administered with the aim of clarifying the importance of oral hygiene and motivating brushing among the volunteers. Written clarifications will also be given in the form of an illustrative pamphlet. The volunteers will be trained in the technique through supervised brushing in front of a mirror. Group 2 will use Colgate Cavity Protection Toothpaste + Colgate Ultrasoft toothbrush. Subjects will be instructed to use only their assigned group during the study period. The treatment products will be re-supplied at regular intervals. Subjects will return with their assigned products to the study site before receiving new products.~There will be no restrictions regarding diet habits during the course of the study. Upon completion of the study, subjects will be instructed to return all used and used products.
Study: NCT05105373

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Parenting for Respectability
Description: The programme addresses main challenges of Parenting and builds skills in 4 main areas~1. Poor parental bonding and child attachment;~2. Harsh parenting~3. Inequitable socialisation by gender~4. Parental conflict.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parenting for Respectability
Description: The programme addresses main challenges of Parenting and builds skills in 4 main areas~1. Poor parental bonding and child attachment;~2. Harsh parenting~3. Inequitable socialisation by gender~4. Parental conflict.
Study: NCT04807842

Intervention type: DEVICE
Group type: OTHER
Intervention: vaginal gel
Description: The placebo gel is a non-buffered gel. The active device is an acidic gel.
Study: NCT05972811

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold application
Description: In the experimental group, cold application will be made until the skin temperature of the drain exit area reaches 13.6 °C. And before drain removal, immediately after drain removal and 15 minutes later, pain levels will be measured with VAS and analgesic needs will be questioned
Study: NCT06392646

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: self-management education program
Description: Intervention through a self-management education program constructed through evidence summarization and expert correspondence.
Study: NCT05427552

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS)
Description: The iTBS will be applied over lDLPFC with three different intensities. The investigators put the NIRS probe under the TMS coil to detect the hemodynamic signal simultaneously, and the applied rMT was adjusted based on Stokes et al., 2007. The equation is AdjMT% = MT + 2.8 \* (Dsitex - Dm1), and the thickness of the probe is 6mm, therefore, 2.8\*6=16.8(%) were added to the normal intensity.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS)
Description: The iTBS will be applied over lDLPFC with three different intensities. The investigators put the NIRS probe under the TMS coil to detect the hemodynamic signal simultaneously, and the applied rMT was adjusted based on Stokes et al., 2007. The equation is AdjMT% = MT + 2.8 \* (Dsitex - Dm1), and the thickness of the probe is 6mm, therefore, 2.8\*6=16.8(%) were added to the normal intensity.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS)
Description: The iTBS will be applied over lDLPFC with three different intensities. The investigators put the NIRS probe under the TMS coil to detect the hemodynamic signal simultaneously, and the applied rMT was adjusted based on Stokes et al., 2007. The equation is AdjMT% = MT + 2.8 \* (Dsitex - Dm1), and the thickness of the probe is 6mm, therefore, 2.8\*6=16.8(%) were added to the normal intensity.
Study: NCT04863846

Intervention type: OTHER
Intervention: No intervention, observational study
Description: Exposure of interest: clinical implementation of an algorithm

Intervention type: OTHER
Intervention: No intervention, observational study
Description: Exposure of interest: clinical implementation of an algorithm
Study: NCT04882306

Intervention type: DEVICE
Group type: OTHER
Intervention: Bilateral MARIA scan
Description: After consent has been given, the participant's breast will be fitted by the operator using a clear plastic cup to determine their corresponding MARIA® cup insert size. Once this has been determined, participants will be required to lie prone with their breast pendent through an aperture in the MARIA® patient bed. The cup insert will contain a layer of coupling fluid. The hemispherical cup inserts, and array are brought into contact with the breast. Depending on the patient's breast size, one or more cup inserts may be placed in the array to ensure a good but non-compressing fit between the breast and the system interface. The scan sequence will then be performed, this takes a couple of minutes.
Study: NCT05194540

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tralokinumab
Description: Tralokinumab is a human recombinant monoclonal antibody of immunoglobulin G4 (IgG4) subclass that specifically binds to human interleukin-13 (IL-13) and blocks interaction with the IL-13 receptors. It is presented as a liquid formulation for subcutaneous administration
Study: NCT06379204

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: the maximum physiological value standardized group
Description: 10 kcal/kg/week for 1-6 weeks, 12.5 kcal/kg/week for 7-12 weeks, exercise frequency of 3d/week, exercise intensity calculated by CPET measurement and HRR heart rate reserve method, gradually increasing.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: the ventilatory threshold individualized group
Description: 10 kcal/kg/week for 1-6 weeks, 12.5 kcal/kg/week for 7-12 weeks, exercise frequency of 3d/week, exercise intensity calculated by CPET measurement and three zone threshold model, gradually increasing.
Study: NCT05024019

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nimotuzumab
Description: The study group received nimotuzumab (200mg, weekly, for 6 weeks) in combination with radiotherapy.
Study: NCT05425472

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR070803
Description: HR070803
Study: NCT05322382

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: A-line
Description: Subjects breathe air mixtures containing reduced amounts of oxygen to produce the desired level of hypoxemia.
Study: NCT05200078

Intervention type: DEVICE
Intervention: Deep inspiration breath-hold technique
Description: Selective application of deep inspiration breath-hold technique
Study: NCT05931887

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SILQ ClearTract 100% Silicone 2-Way Foley Catheter
Description: A foley catheter is assigned and used according to regular standard of care

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SILQ ClearTract 100% Silicone 2-Way Foley Catheter
Description: A foley catheter is assigned and used according to regular standard of care
Study: NCT05222373

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT-based lifestyle intervention
Description: The standard care plus a theoretically-based, diet, activity, and mental health lifestyle intervention integrated within a culturally sensitive curriculum (materials in Spanish and English). Trained CHWs will promote CBT-based lifestyle-change aims and assist in goal setting with participants to reach the primary goal of appropriate glycemic control (fasting blood glucose and HbA1c) and weight reduction, in addition to decrease in depressive symptoms and stress and an increase in quality of life. Participants' body weight, body composition, metabolic measures, and mental health outcomes will be obtained at enrollment and at the end of the intervention.
Study: NCT06377787

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ELDOA and conventional therapy
Description: hot pack and TENS for10 min, cervical PIR (MET) in flexion, extension, side bending and rotation (single set of 4rep with 6 sec hold once a day) and ELDOA method C0-C1-C2, C2 \& C3 positions for cervical spine (2 sets of five repetitions with 45 sec hold and 15sec rest between each set once a day).

Intervention type: OTHER
Group type: OTHER
Intervention: conventional therapy
Description: include hot pack and TENS for 10 minutes, cervical PIR (MET) in flexion, extension, side bending and rotation (single set of 4 reps with 6 seconds hold once a day).
Study: NCT05298891

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual clinical practice + hypoproteic diet
Description: Diet will be composed by:~* energy equal to daily energy expenditure (estimated by indirect calorimetry \* physical activity factor)~* fats 28-35%~* carbohydrates 50-60%~* proteins 0,7-0,8g/kg of body weight 10-13% Diet will be given to the patient after the first visit and the study will start once the patient begins the diet.
Study: NCT06493773

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Offer of referral to specialized alcohol use disorder treatment
Description: Patients are offered referral to specialized alcohol use disorder treatment.
Study: NCT04833088

Intervention type: OTHER
Group type: OTHER
Intervention: Focus group discussions
Description: Focus group discussions will be organized to investigate the needs and requirements of the participants in terms of three pre-defined user scenarios.

Intervention type: OTHER
Group type: OTHER
Intervention: Focus group discussions
Description: Focus group discussions will be organized to investigate the needs and requirements of the participants in terms of three pre-defined user scenarios.

Intervention type: OTHER
Group type: OTHER
Intervention: Focus group discussions
Description: Focus group discussions will be organized to investigate the needs and requirements of the participants in terms of three pre-defined user scenarios.

Intervention type: OTHER
Group type: OTHER
Intervention: Focus group discussions
Description: Focus group discussions will be organized to investigate the needs and requirements of the participants in terms of three pre-defined user scenarios.
Study: NCT06460090

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Happy Talk
Description: A targeted selective speech language and communication programme embedded in the community, designed for people livling in social disadvantage.
Study: NCT04784182

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: probiotic plus prebiotic supplement
Description: Daily consumption of probiotic containing at least 5 billion CFU per day total bacteria including Lactobacillus helveticus and Bifidobacterium longum and prebiotic containing 4 grams of fructooligosaccharides (FOS)

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Daily consumption of visually similar placebo pills
Study: NCT04944160

Intervention type: OTHER
Intervention: Medical records analysis
Description: To review of medical records to describe diagnosis and severity of the disease.

Intervention type: OTHER
Intervention: Medical records analysis
Description: To review of medical records to describe diagnosis and severity of the disease.

Intervention type: OTHER
Intervention: Comparison of cohorts
Description: To compare pre and post Covid-19 epidemics in terms of numbers of admissions, and proportion of severe disease.

Intervention type: OTHER
Intervention: Comparison of cohorts
Description: To compare pre and post Covid-19 epidemics in terms of numbers of admissions, and proportion of severe disease.
Study: NCT04962022

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07321332/ritonavir
Description: Administered orally every 12 hours for days for a total of 5 doses from Day 1 through Day 3

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Administered orally once daily for 8 days from Days 1 through 8

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07321332/ritonavir
Description: Administered orally BID for 3 day for a total on 5 doses starting on Day 4 through Day 6
Study: NCT04309227

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength Training
Description: Strength training traditionally requires use of high intensity loads to stimulate muscle growth and strength improvements. Some participants will be randomized to a traditional strength training program.~Blood Flow Restriction (BFR) training is used to stimulate muscle hypertrophy and strength improvements in a variety of populations. Results of BFR training are comparable to traditional high intensity training (HIT) despite using weight that are at a low intensity (low percent of 1 repetition maximum). This intervention has not been extensively studies in the rheumatoid or osteoarthritis populations, nor the myositis populations despite idealogical benefit for each group of low-load strengthening.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength Training
Description: Strength training traditionally requires use of high intensity loads to stimulate muscle growth and strength improvements. Some participants will be randomized to a traditional strength training program.~Blood Flow Restriction (BFR) training is used to stimulate muscle hypertrophy and strength improvements in a variety of populations. Results of BFR training are comparable to traditional high intensity training (HIT) despite using weight that are at a low intensity (low percent of 1 repetition maximum). This intervention has not been extensively studies in the rheumatoid or osteoarthritis populations, nor the myositis populations despite idealogical benefit for each group of low-load strengthening.
Study: NCT05725616

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Coronary angiography
Description: Snuff Box Approach or radial Arterial Approach at wrist for coronary angiography.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary angiography
Description: Snuff Box Approach or radial Arterial Approach at wrist for coronary angiography.
Study: NCT04951037

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fully Asynchronous Online Savvy Program
Description: The intervention is a fully online, self-administered psychoeducational program designed to enhance caregiver mastery for family and friends providing unpaid care for living with Alzheimer's and similar dementia disorders. Participants will be asked to engage with a fully online version of Tele-Savvy for 42 days.~Participants will receive a series of daily video lessons related to caregiving. These lessons are generally 8-15 minutes in length and are emailed to participants. Participants can watch the lessons whenever and as often as they wish over the course of the study. There will also be self-guided learning strategies and exercises to accomplish skill and mastery related to the caregiving role. The lessons cover a variety of topics including:~* Facts about dementing Illnesses~* Caregiving Strategies - guiding the person through days that are as safe, calm, and pleasant as possible~* Self-Care for the Caregiver
Study: NCT05416762

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 5mg
Description: Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 5mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 10mg
Description: Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 10mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 20mg
Description: Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 20mg
Study: NCT05326945

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Presence or Absence of a Blood Pressure Cuff Sheath
Description: Monitoring of microorganism transfer from the sphygmomanometer to the patient, from the patient to the sphygmomanometer in case the sheath designed in the research is put on or not before the blood pressure measurement process
Study: NCT06268743

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity
Description: High intensity exercise

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Moderate intensity
Description: Moderate intensity exercise